West Pharmaceutical Services, Inc. last reported quarterly results on Oct 29, 2026, for Q3 FY2026 (the quarter ended Sep 30, 2026): revenue of $874.5 million (+8.7% year over year) and diluted EPS of $3.02. It usually reports 23–43 days after a quarter ends. Based on that pattern, the next release is estimated for around Feb 11, 2027.
Results for Q4 FY2026, the quarter ending around Dec 31, 2026. Expected on a Thursday. Based on last year's release for the same quarter on Feb 12, 2026. This is an estimate, not a date the company has announced.
Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 23–43 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.
| Released | Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|---|
|
Oct 29, 2026
29 days after quarter end
|
Q3 FY2026
ended Sep 30, 2026
|
874
+8.7%
|
214
+52.9%
|
3.02
+57.3%
|
|
Jul 23, 2026
23 days after quarter end
|
Q2 FY2026
ended Jun 30, 2026
|
872
+13.8%
|
154
+16.8%
|
2.15
+18.1%
|
|
Apr 23, 2026
23 days after quarter end
|
Q1 FY2026
ended Mar 31, 2026
|
845
+21.0%
|
139
+54.6%
|
1.92
+56.1%
|
|
Feb 12, 2026
43 days after quarter end
|
Q4 FY2025
ended Dec 31, 2025
|
805
+7.5%
|
132
+1.5%
|
1.82
+2.5%
|
|
Oct 23, 2025
23 days after quarter end
|
Q3 FY2025
ended Sep 30, 2025
|
805
+7.7%
|
140
+2.9%
|
1.92
+3.8%
|
|
Jul 24, 2025
24 days after quarter end
|
Q2 FY2025
ended Jun 30, 2025
|
766
+9.2%
|
132
+18.4%
|
1.82
+20.5%
|
|
Apr 24, 2025
24 days after quarter end
|
Q1 FY2025
ended Mar 31, 2025
|
698
+0.4%
|
90
-22.1%
|
1.23
-20.6%
|
|
Feb 13, 2025
44 days after quarter end
|
Q4 FY2024
ended Dec 31, 2024
|
749
+2.3%
|
130
-5.0%
|
1.77
-3.3%
|
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- WST (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- PA
- Headquarters
- Exton, PA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 105770
- Former names
- WEST CO INC (until Feb 11, 1999)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.